Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
@Robot
List 2 bad picks.
Cheers!
Foxwoods
You are correct. I said this yesterday:
Fosco
Robots opinions have been worthless, as you know, so do not suffer fools.
Further, the 4/15 date is NOT a deadline. It is not the date Data will be out by. It is a placeholder for the CT site.
I suspect 4/15 will come and go with out data.
Yup...I said that 4/15 will come and go with out data IMO. Read what I said again and then again
Cheers!
Short Interest Up
8.2M. 21% float
https://www.wsj.com/market-data/quotes/CVM
INCORRECT
GAVIN NEVER SAID DATA BY 4/15! That is either a LIE or a misunderstanding
CALL HIM IF YOU DOUBT ME!
Data will come either before, on or after 4/15
Cheers!
@Tickle
Yes. He holds conf calls with larger investors from time to time.
Nothing material was discussed. Same stuff he says in his interviews and tweets. Honestly, nothing new.
Ask Mike From San Diego (on stocktwits) to hook you up on the calls
RE: $CTXR
Its a home run. Ive made a big commitment to it. well over 6 digits in shares. I got into CTXR last June and have been averaging up
Give a look at $ATNF. SHORT TERM TRADE. 78% shares short. 3M float
@Tickle
Not true.
He hosted a call for message board members on Monday
Shame you werent on the call
Cheers!
While I Wait For Data...
I have been branching out. Need to diversify and keep engaged as CVM is a bore until data.
Check out $ATNF
78% short
3M Float
I alerted everyone at $6.00 late last week. Just hit $7.20
Price target of $13 very soon
https://seekingalpha.com/instablog/50299941-north-shore-research/5566082-atnf-low-float-high-short
@WHSMITE
SOLID!
YOu are a smart cookie!
I will be tweeting an sharing that EVERYWHERE!!!!
You kiss your mom with that mouth?
Off to ignore with the other morons
So many clueless noobs
It amazes me how many morons are on Message Boards
Cheers!
@Remit
Thanks! I had not seen that one
Ill do my thang with it
Cheers!
@GD
You said “ I do not have a calculator, but I have paid a huge tuition to learn
from many many small biotech PIII trials with event delays not from
drug efficacy but from better SOC and better patient selections
that make the control arm patients live much longer than expected. “
I’m speechless. You have paid “ huge tuition” but the number of times and things you have gotten wrong about CVM over the years is too many to count
You will again be wrong this Friday.
You also will be wrong when data come out afterwards and it’s positive
Cheers
@bio
Well done. I commend you on your commitment and efforts. You haven’t stop digging. Always logical and verifiable
I’m burnt on CVM DD. Fosco and I did tons of DD for many years.
We are now at the end. We are so close. I’m 100% locked in for data. Just burnt out Cvm and have been using capital to invest in some other biotechs (CTXR is my second largest holding). Keeps me engaged to learn about other companies
I also have a very good sense of timing.
Cheers
New video
@GD
I dont expect data next week. Ill be right again
Cheers!
W W
Thanks. Fixed. my mistake. Sloppy. Sorry
WHO IS THE MOST SHORTED COMPANY?
Not CVM.... But its....
$ATNF
Crazy at 78%!
https://www.marketwatch.com/tools/screener/short-interest?mod=side_nav
Im long and blogged about it here
https://seekingalpha.com/instablog/50299941-north-shore-research/5566082-atnf-low-float-high-short
W W
What were the 5 primary endpoints
Cheers
OT:CYDY & Confirmation Bias
Confirmation Bias is amazing
I see CYDY came out with its data announcement late Friday and a follow-up PR last night. Never good to get PRs after hours on a Friday.
It appears to me that it missed efficacy on all primary...but the CYDY longs on the boards appear to be happy. They believe it succeeded.
What am I missing? They did report some success on a subgroup of a subgroup, but I suspect the market will destroy the stock Monday
I have NO position but interested in how this is playing out. Confirmation Bias always intrigues me. Its dangerous.
Seems confirmation bias is really taking over at CYDY.
I did say on 2/22 that CYDY would fail and it would trade around $1
Tomorrow will be interesting. Currently trading around $4
Good luck to all
Cheers!
GK DROPS OUT OF CONFERENCE
Very interesting!
Per Investor Relations at CEL-SCI, Geert was scheduled to present next week at the "GLOBAL LIFE SCIENCES CONFERENCE", but...
Geert is NO LONGER presenting and has pulled out of the conference.
Why would GK pull out now?
All this is 100% confirmable with Investor Relations at CVM
Cheers!
@james
One thing I have learned about Robot, he has provided nothing useful in all the years here
When held accountable to his words, he gets upset
Words matter and they should!
Cheers!
LOL!!!
Thats it!? Thats nothing and meaningless
Cheers!
ROBOT: Please provide link to this statement:
"Redditt will go after the shorts on CVM today"
Jim
Solid
Ive downloaded and I am reviewing now. Ive forwarded to FOsco too
I have also texted you.
Did you match up the event count from the data leak from Taiwan? I dont see it
Date Simulation Observed Source
Feb-4-17 114 with 23.5% OSI 114 Taiwan IRB
Feb-3-18 178 with 30% OSI 178 Taiwan IRB
Apr-20-20 298 - 24.5% OSI 298 CVM publication
Regards,
Sushi
Or...
He wanted to keep the stock above $20 for 10 trading days
Dont think the thought hasnt crossed my mind
Cheers!
Gotta keep it real 24/7
The fluffers are upset.
We will see likely $19s today or tomorrow.
The short crew will try to push down below the $20 strike. Nearly 4K of Open Interest there.
They want it below $20.00 by OpEx Tomorrow.
They will likely achieve that.
Cheers
Coffee Update
While I am surprised it took this long, everything I posted on 2/2/21 still holds true
I expect us to level off in the $18s
Not happy about it...but facts are facts. Charts dont lie. There was NO REASON to be in the $40s, the $30s and now the $20s
We will get back to the $20s before data, that I am certain of.
Data is expected in March by me, April by Fosco and Late June/Early July by Biobonic
Cheers!
@GD
I didnt win anything. Im sorry you lost money!
I dont relish ppl losing money when they are long CVM. Im sorry you will not get data this week.
I want data asap! Ive been here 11 years! 11 effing years!
But I dont see it coming until March. Fosco says April. Biobonic is late June/Early July
So, I plan on waiting
I always give my opinion based on Facts and assumptions. People think my posts are meant to manipulate. Its fine. I dont care.
Had they listened to me in June, August, etc when I said no data lock...they could of made money selling covered calls
Their loss for not heeding my wisdom
Cheers!
PR OUT! NO DATA THIS WEEK
In December 2020, CEL-SCI updated the status of its pivotal Phase 3 head and neck cancer study of Multikine* (Leukocyte Interleukin, Injection). Data lock has been completed, and the study entered its final stage of statistical analysis. CEL-SCI remains blinded to the study data and is not involved in this process which is conducted by independent contractors. The statistical analysis plan follows the protocol stated objectives and is designed to meet FDA requirements to define the clinical benefits that Multikine might provide for patients newly diagnosed with advanced primary (not yet treated) squamous cell carcinoma of the head and neck. The analysis looks at multiple parameters to gain the most information on the possible benefits of using Multikine immunotherapy as a first line treatment before standard of care for these patients.
CEL-SCI continued expanding and upgrading its dedicated cGMP facility in which it manufactures Multikine. The construction, which began in 2020, is expected to be completed in the coming months and will double the facility’s capacity to accommodate two shifts for increased production of Multikine.
In December 2020, CEL-SCI announced that its LEAPS COV-19 peptides, delivered as a therapeutic treatment following SARS-CoV-2 virus challenge, achieved a 40% survival rate in human ACE2 transgenic mouse model as compared to 0% survival in the two control groups. These studies were conducted at the University of Georgia Center for Vaccines and Immunology. As COVID-19 mutations increase, LEAPS COV-19’s mechanism of action which targets the non-mutating part of the SARS-CoV-2 virus is becoming more important.
GD
Geert Luck to you today/this week.
Your win, is our win
Cheers!
@GD
Im not sure if you saw GK's tweet yesterday
@Bio
Interesting. I love when opinions and guesses are based on facts/assumptions
Hard to argue with your analysis. Biggest variable I see is your assumption DBL occurred on 12/7. I have always stated that DBL occurred in November. That’s 3-4 weeks sooner than your estimate
July, huh? Using my DBL would be early/mid June.
Hmmm, must think about your analysis and ponder
Cheers
@Bio
A few years ago, I spent time on the various cancer and HNC forums.
There was some talk of Multikine, not much
I tried to get some feedback from participants, to no avail
Cheers!
Are you ready to play Math, boys and girls?
From the 10Q:
“The company estimates it will incur additional expenses of approximately $5.1 million for the remainder of the Phase 3 trial. Cost of Multikine for three months ended December 31 was $5.0 million"
If it took 3 months to spend $5M on PH3 work in the 3 months ended 12/31...how long do you think it will take to spend the "estimated" $5.1M in remaining expenses?
3 months? Winner!
Data in March or April at the latest!
Cheers!!!
10Q
Plenty of cash plus $3.9M post 12/31 from converted warrants
Wrrts were extended as I suggested, I know GK
Cheers
@Biobonic
Great post as always
He has ONE shot to get this right and he will take all the time needed to do so
Cheers!
@Biobonic
Skiing is geert this time of year for sure!
You havent opined, and perhaps you care not to, on data timing
Care to opine on timing?